Background illustration for clinical trials search

Paid Clinical Trials Richardson

Discover 1,933 paid clinical trials in Richardson, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

for
Melanoma (Skin Cancer),
Location: Dallas TX, Austin TX, Houston TX, Laredo TX, Fairway KS,
Sponsor: Aminex Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07287917

Phase 1, Phase 2, Recruiting

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

for
Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC),
Location: Dallas TX, Tyler TX, Austin TX, Houston TX,
Sponsor: Stingray Therapeutics

Sex: All

Age: 18+

Code: NCT06589440

Phase 2, Recruiting

Vitamin D Homeostasis in Sarcoidosis

for
Sarcoidosis, Vitamin D Insufficiency
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 21+

Code: NCT03621553

Recruiting

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

for
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma,
Location: Dallas TX, Houston TX, Little Rock AR, Nashville TN,
Sponsor: Caribou Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04637763

Phase 1, Recruiting

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

for
Advanced Solid Malignancies
Location: Dallas TX, Irving TX, Nashville TN, Louisville KY,
Sponsor: Georgiamune Inc

Sex: All

Age: 18+

Code: NCT06028074

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

for
Advanced/Metastatic Solid Tumors, Colorectal Cancer,
Location: Dallas TX, Tyler TX, Oklahoma City OK, Houston TX,
Sponsor: Merus B.V.

Sex: All

Age: 18+

Code: NCT03526835

Phase 1, Phase 2, Recruiting

Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers

for
Diabetic Foot Ulcer
Location: Dallas TX, Houston TX, McAllen TX, O'Fallon IL,
Sponsor: Piomic Medical

Sex: All

Age: 22 - 70+

Code: NCT05758545

Recruiting

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

for
Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy,
Location: Dallas TX, Houston TX, Nashville TN, Aurora CO,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07223203

Phase 3, Recruiting

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Dallas TX, Houston TX, Denver CO, Nashville TN,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06108050

Phase 1, Recruiting

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

for
Breast Cancer
Location: Dallas TX, San Antonio TX, Nashville TN, Salem VA,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT05748834

Phase 2, Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for
Breast Cancer
Location: Dallas TX, Allen TX, Abilene TX, Tulsa OK, Houston TX,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase 3, Recruiting

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer (NSCLC)
Location: Dallas TX, Lincoln NE, Nashville TN, Atlanta GA,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT07288177

Phase 2, Recruiting

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

for
Hematopoietic Cell Transplant, Solid Organ Transplant,
Location: Fort Worth TX, Houston TX, Little Rock AR, Memphis TN,
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 0 - 18

Code: NCT05550298

Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

for
Endometrial Cancer, Cervical Cancer, Ovarian Cancer,
Location: Fort Worth TX, Houston TX, San Antonio TX,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT06293898

Phase 1, Recruiting

KRT-232 and TKI Study in Chronic Myeloid Leukemia

for
Chronic Myeloid Leukemia
Location: Dallas TX, Birmingham AL, Milwaukee WI, Augusta GA,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04835584

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

for
Recurrent or Metastatic Solid Tumors
Location: Dallas TX, Pearland TX, Amarillo TX, Germantown TN,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06330064

Phase 1, Phase 2, Recruiting

Tesetaxel as First-line Therapy for Metastatic Breast Cancer

for
Breast Neoplasm
Location: Dallas TX, Greensboro NC, New York NY
Sponsor: Genta Incorporated

Sex: Female

Age: 18+

Code: NCT01221870

Phase 2, Recruiting

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

for
Prediabetic State, Atherosclerosis, Metformin
Location: Dallas TX, Houston TX, Little Rock AR, Memphis TN,
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT02915198

Recruiting

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Dallas TX, Springfield MO, Kansas City MO, Columbia MO,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06369285

Phase 2, Recruiting

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

for
Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases,
Location: Grapevine TX, Tulsa OK, Sugar Land TX, San Antonio TX,
Sponsor: Eli Lilly and Company

Sex: All

Age: 6 - 17

Code: NCT05723198

Phase 3, Recruiting